AzTrials
AzTrials

Endoscopic Surgical ProcedureGESICANCT05128604

Endoscopic Ultrasound-Guided Gastroenterostomy Nationwide: Prospective Registry.

An observational study of Endoscopic Surgical Procedure and Safety, run by Hospital Universitari de Bellvitge at 6 sites in Spain.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This is project of help and support for the introduction of the GASTROENTEROANASTOMOSIS technique guided by ENDOSCOPIC -ULTRASOUND (EUS-GE) in centers in Catalonia, facilitating a teacher training. Read more about this study

Who is it for?
Any age
Conditions the study is for
Endoscopic Surgical Procedure, Safety, Training
What is being tested?
Gastroenterostomy
Type of treatment
Medical device
How many people
50 participants
Where
6 sitesSpain
Study dates
23 May 2022to 24 Sep 2026
How long will I take part?
6 Months
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: Patients with sympotmatic Gastric outlet obstruction (GOO) related to malignant or notn-malignant conditions.

Who may be able to join

  • Age 18 years or more
  • Gastric outlet obstruction (GOO) caused by passable /unpassable stenosis in the antrum-duodenal region, to malignant or non-malignant conditions
  • Patient capable of understanding and signing informed consent form
  • Patient understanding the type of study and complying with the follow-up of complementary tests during the study's duration

Who cannot join

  • Massive ascites.
  • Complete stenosis
  • Failure to sign informed consent form
  • Patients with intellectual handicap who are unable to understand the nature and possible consequences of the study, unless there is a competent legal representative
  • Patients unable to adhere to subsequent follow-up requirements
  • Severe coagulation disorder: INR > 1.5 not correctible with administration of plasma and/or platelets < 50,000/mm3

Trial locations and contacts

6 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Joan Gornals, MD, PhD contact

+34932607682

jbgornals@bellvitgehospital.cat

6 sites in 1 country

Spain6 sites, 6 recruiting
  • Hospital Universitari Germans Trias i Pujol (Can Ruti)

    Badalona, Barcelona, Catalonia, 08916

    Juan A Colán, MD, 00 (34) 934 65 12 00, jacolanh.germanstrias@gencat.cat

    00 (34) 934 65 12 00

    Recruiting
  • Hospital de la Santa Creu i Sant Pau

    Barcelona, Barcelona, 08041

    Charlie guarner Argente, MD, PhD, 00 (34) 932919000, CGuarnerA@santpau.cat

    00 (34) 932919000

    Recruiting
  • Hospital Del Mar

    Barcelona, Catalonia

    Luis Barranco, MD, 00 (34) 932 48 30 00, luisbarranco@gmail.com

    00 (34) 932 48 30 00

    Recruiting
  • Hospital Universitari de Girona Doctor Josep Trueta

    Girona, Catalonia, 17007

    Carlos Huertas, MD, PhD, 00(34) 972 94 02 00, chuertas.girona.ics@gencat.cat

    00(34) 972 94 02 00

    Recruiting
  • Hospital Universitari de Bellvitge

    L'Hospitalet de Llobregat, Barcelona, Catalonia, 08907

    Joan B Gornals, MD, PhD, +34 93 260 76 82 ext. 2624, jgornals@bellvitgehospital.cat

    Daniel Luna, MD, +34 93 260 76 82 ext. 2624, danii.luna23@gmail.com

    Recruiting
  • Hospital Universitari Mútua de Terrassa

    Terrassa, Barcelona, Catalonia, 08221

    Carme Loras, MD, PhD, 00 (34) 937 36 50 50, clorasalas@gmail.com

    00 (34) 937 36 50 50

    Recruiting

Other trials in Spain

About this study

Official title: Introduction Of Endoscopic Ultrasound-Guided Gastroenterostomy Based On A Learning Protocol And Prospective Registry.

This is project of help and support for the introduction of the GASTROENTEROANASTOMOSIS technique guided by ENDOSCOPIC -ULTRASOUND (EUS-GE) in centers in Catalonia, facilitating a teacher training.

The main objective is facilitate a safe introduction of the technique, limiting technical failures, and if necessary, support in rescue techniques.

Read more

The goal of this interventional study is to assess the impact of a teaching and on live-support model in the introduction of the gastroenteroanastomosis technique, evaluating its effects in safety and the learning curve.

regarding the results in safety and learning curve of for the introduction [type of study: observational study or clinical trial] is to [learn about, test, compare etc.] in [describe participant population/health conditions]. The main question[s] it aims to answer are:

  • [question 1]
  • [question 2] Participants will [describe the main tasks participants will be asked to do, treatments they'll be given and use bullets if it is more than 2 items]. If there is a comparison group: Researchers will compare [insert groups] to see if [insert effects].
Being tested
Gastroenterostomy
Keywords
endoscopic ultrasound, gastroenterostomy, lumen apposing stent

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • GastroenterostomyDevice

    Also called Endoscopic ultrasound, Lumen apposing stent

    Endoscopic ultrasound guided gastroenterostomy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Safety introduction of EUS-gastroenterostomy

    To determine the safety of this interventional technique, measuring prospectively the adverse events and incidents after after a learning project for helping to introduce this technique.

    Measured: 12 months

Secondary outcomes (1)
  1. Learning curve

    To assess the number of procedures related to a competence in the EUS-Gastroenterostomy

    Measured: 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Nov 2021
  2. Study start23 May 2022
  3. Primary completion24 Mar 2026 (estimated)
  4. Study completion24 Sep 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
50 participants (estimated)
Target duration
6 Months
IDs, dates and publications
ClinicalTrials.gov ID
NCT05128604
Sponsor's protocol ID
GESICA
Acronym
GESICA
Status last verified
Jul 2025
First submitted
11 Jul 2021
Last updated
29 Jul 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Endoscopic Surgical Procedure and Safety, run by Hospital Universitari de Bellvitge at 6 sites in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 29 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 6 sites in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Joan Gornals, MD, PhD (+34932607682, jbgornals@bellvitgehospital.cat), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Safety introduction of EUS-gastroenterostomy (time frame: 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Jul 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in